StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

PDS Biotechnology's enterprise value was $51.44M on Nov 11, 2026, against $10.58M a year earlier. Over the last 5 years it ranged from $3.52M to $304.01M, with a median of $59.59M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$51.44M+388.8%
2025Dec 31, 2025$10.52M+2.5%
2024Dec 31, 2024$10.27M-89.7%
2023Dec 29, 2023$99.86M-67.2%
2022Dec 30, 2022$304.01M+89.3%
2021Dec 31, 2021$160.58M+1033.2%
2020Dec 31, 2020$14.17M–
2019Dec 31, 2019-$3.42M-117.1%
2018Dec 31, 2018$19.97M-95.8%
2017Dec 29, 2017$480.99M-21.2%
2016Dec 30, 2016$610.10M–
2015Dec 31, 2015-$10.67M–

More PDS Biotechnology figures

See a number that looks wrong?